[Ip-health] Call for Applications to Serve on the Medicines Patent Pool's Tuberculosis Sub-Group

Katie Moore kmoore at medicinespatentpool.org
Mon Jan 15 08:38:43 PST 2018


Call for Applications to Serve on the Medicines Patent Pool’s Tuberculosis (TB) Sub-Group

The Medicines Patent Pool is inviting interested persons to serve on the TB Sub-Group of the Expert Advisory Group (EAG). The EAG provides expert advice to the MPP’s Governance Board and Executive Director, particularly with respect to ongoing negotiations that the MPP is engaged in, and evaluates the final results of negotiations to determine whether a proposed licence agreement meets MPP’s stated goals and offers significant public health benefits. The terms of reference for the EAG can be found here: www.medicinespatentpool.org/uploads/2017/06/EAG-ToR-final-25-January-2017.pdf<http://www.medicinespatentpool.org/uploads/2017/06/EAG-ToR-final-25-January-2017.pdf>

The Expert Advisory Group is divided into three sub-groups covering the three disease areas that the MPP works in: HIV, hepatitis C and tuberculosis. The composition and structure of the EAG can be found here:
www.medicinespatentpool.org/who-we-are/governance-team/expert-advisory-group/<http://www.medicinespatentpool.org/who-we-are/governance-team/expert-advisory-group/>

The MPP is now seeking a candidate to serve on the TB Sub-Group, and in particular is seeking someone who brings expertise in intellectual property law and/or licensing. Members of the EAG serve in their personal capacity and on a non-remunerated basis.

Interested applicants should send their C.V. and a motivation letter to office at medicinespatentpool.org<mailto:office at medicinespatentpool.org> by 15 February 2018.


About the Medicines Patent Pool
The Medicines Patent Pool is a United Nations-backed public health organisation working to increase access to HIV, hepatitis C and tuberculosis treatments in low- and middle-income countries. Through its innovative business model, the MPP partners with industry, civil society, international organisations, patient groups and other stakeholders to prioritise, forecast and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, the MPP has signed agreements with nine patent holders for thirteen HIV antiretrovirals, one HIV technology platform, two hepatitis C direct-acting antivirals and a tuberculosis treatment. The MPP was founded and is funded by Unitaid.


Katherine Moore| Head of Communications | Medicines Patent Pool
Website<http://www.medicinespatentpool.org/> | Newsletter<http://www.medicinespatentpool.org/news-room/newsletter/> | Twitter<http://twitter.com/MedsPatentPool> | LinkedIn<http://www.linkedin.com/company/medicines-patent-pool>
Tel: +41 22 533 5054 | Mobile: +41 79 825 4786
Email: kmoore at medicinespatentpool.org<mailto:kmoore at medicinespatentpool.org>



More information about the Ip-health mailing list